1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Event rate and outcomesa
Events and Outcomes Bilateral Group Unilateral Group P Value Simultaneous (n = 24) Staged (n = 6) Control (n = 175) Hyperperfusion syndrome 4 0 5 .036 Hemodynamic depression 7 3 49 .505 6-month event Minor stroke 2 (2) 0 8 (6) 1.000 Major stroke 0 0 4 (4) 1.000 Death 1 0 7 (2) .550 6-month outcome mRs ≤2 23 6 158 .830 mRs >2 1 0 17 Restenosis 3/36 (8.3%) 0/12 9/132 (6.8%) .321 Total deaths 1 0 7 .676
a The number in parentheses in a 6-month event refers to a 1-month event.